Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Champions Oncolog (CSBR)

Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million ACCESSWIRE - Wed Dec 11, 10:00AM CST

HACKENSACK, NJ / ACCESSWIRE / December 11, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced...

CSBR : 7.51 (-0.60%)
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 ACCESSWIRE - Thu Dec 5, 10:30AM CST

HACKENSACK, NJ / ACCESSWIRE / December 5, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report...

CSBR : 7.51 (-0.60%)
Champions Oncology Announces Agreement with Weill Cornell Medicine ACCESSWIRE - Wed Oct 16, 5:55AM CDT

HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing agreement...

CSBR : 7.51 (-0.60%)
Wall Street - New York Stock Exchange during sunrise by Deberarr via iStock
Stocks Rise Before the Open as Investors Await Key U.S. PPI Data, ECB Decision in Focus Barchart - Thu Sep 12, 4:41AM CDT

September S&P 500 E-Mini futures (ESU24) are up +0.24%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.27% this morning as investors braced for crucial U.S. producer inflation data while also...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
FSLR : 182.39 (+3.70%)
ENPH : 71.45 (+8.59%)
ARM : 132.15 (+0.04%)
NVDA : 134.70 (+3.08%)
ALB : 88.65 (-0.30%)
GME : 29.82 (+2.83%)
ADBE : 447.17 (+2.24%)
ROG.Z.IX : 246.800 (+0.45%)
OXM : 81.03 (-0.55%)
CSBR : 7.51 (-0.60%)
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 ACCESSWIRE - Mon Sep 9, 11:00AM CDT

HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its...

CSBR : 7.51 (-0.60%)
Champions Oncology Reports Quarterly Revenue of $12.9 Million AccessWire - Thu Jul 21, 2022

Record Annual Revenue of $49.1 Million

CSBR : 7.51 (-0.60%)
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 AccessWire - Thu Jul 14, 2022

HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic...

CSBR : 7.51 (-0.60%)
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics AccessWire - Tue May 31, 2022

HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...

CSBR : 7.51 (-0.60%)
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo AccessWire - Tue May 3, 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

CSBR : 7.51 (-0.60%)
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million AccessWire - Tue Mar 15, 2022

HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic...

CSBR : 7.51 (-0.60%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - 1 hour ago
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot